Home > Publications database > Breast Cancer Metastatic Progression Requires mRNA Posttranscriptional Suppression. > print

001     277770
005     20240229155023.0
024 7 _ |a 10.1158/0008-5472.CAN-23-1729
|2 doi
024 7 _ |a pmid:37470809
|2 pmid
024 7 _ |a 0099-7013
|2 ISSN
024 7 _ |a 0008-5472
|2 ISSN
024 7 _ |a 0099-7374
|2 ISSN
024 7 _ |a 1538-7445
|2 ISSN
024 7 _ |a altmetric:151754993
|2 altmetric
037 _ _ |a DKFZ-2023-01485
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Amaya Ramirez, Cinthia Claudia
|0 P:(DE-He78)1f71ccf4137962d5dbf12200b9ffa75d
|b 0
|e First author
|u dkfz
245 _ _ |a Breast Cancer Metastatic Progression Requires mRNA Posttranscriptional Suppression.
260 _ _ |a Philadelphia, Pa.
|c 2023
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1691757466_20939
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:B250#LA:B250# / 2023 Aug 1;83(15):2448-2449 / IN THE SPOTLIGHT
520 _ _ |a Cancer cell survival is highly dependent on its metabolic reprogramming, which supports not only cell growth but also confers to the tumor cells characteristics to initiate migration and colonization. Among the different mechanisms that are involved, translational control plays a significant role in oncogenesis; however, its impact on cancer progression still remains poorly understood. A study by Navickas and colleagues revealed that the RNA-binding protein heterogeneous nuclear ribonucleoprotein C (HNRNPC) functions as a translational regulator, and its downregulation in highly metastatic cells leads to the lengthening of 3' untranslated regions in HNRNPC-bound mRNAs, resulting in translational repression mediated by the AGO-miRNA RNA-induced silencing complex.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Loayza-Puch, Fabricio
|0 P:(DE-He78)4af0380446b05b5f1995502016151a1b
|b 1
|e Last author
|u dkfz
773 _ _ |a 10.1158/0008-5472.CAN-23-1729
|g p. OF1 - OF2
|0 PERI:(DE-600)2036785-5
|n 15
|p 2448-2449
|t Cancer research
|v 83
|y 2023
|x 0099-7013
909 C O |p VDB
|o oai:inrepo02.dkfz.de:277770
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)1f71ccf4137962d5dbf12200b9ffa75d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)4af0380446b05b5f1995502016151a1b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-12
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER RES : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-24
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-24
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b CANCER RES : 2022
|d 2023-10-24
920 2 _ |0 I:(DE-He78)B250-20160331
|k B250
|l B250 NWG Translationskontrolle und Stoffwechsel
|x 0
920 1 _ |0 I:(DE-He78)B250-20160331
|k B250
|l B250 NWG Translationskontrolle und Stoffwechsel
|x 0
920 0 _ |0 I:(DE-He78)B250-20160331
|k B250
|l B250 NWG Translationskontrolle und Stoffwechsel
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B250-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21